Skip to main content
GREEN LIFESCIENCE CO., LTD. logo

GREEN LIFESCIENCE CO., LTD. — Investor Relations & Filings

Ticker · 114450 ISIN · KR7114450000 KO Manufacturing
Open in API
Filings indexed 179 across all filing types
Latest filing 2021-03-03 Proxy Solicitation & In…
Country KR South Korea
Listing KO 114450

About GREEN LIFESCIENCE CO., LTD.

https://www.greenlifescience.net/

GREEN LIFESCIENCE CO., LTD. specializes in the development, production, and sale of raw materials and intermediates for various industries. The company's primary offerings include active pharmaceutical ingredients (APIs) and intermediates for pharmaceuticals, as well as raw materials for agrochemicals. It also manufactures fine chemical products and intermediates for electronic materials. The company focuses on providing customized chemical solutions to its clients in the pharmaceutical, agricultural science, and specialty chemical sectors.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Solicitation of Proxy' (의결권대리행사권유참고서류) filed by KPX Life Science. It contains detailed information regarding the upcoming Annual General Meeting (AGM), including the agenda (approval of financial statements, appointment of directors, remuneration limits), voting procedures (electronic voting, proxy solicitation), and financial data for the preceding fiscal year. This document is a formal proxy statement used to solicit shareholder votes for a meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2021-03-03 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for KPX Life Science. It outlines the date, location, and agenda items (such as financial statement approval and director appointments) for the upcoming meeting. This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2021-02-22 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from KPX Life Science regarding a significant change (over 30%) in revenue and profit/loss structure. It provides a comparative table of financial data between the current and previous fiscal years, identifies the cause of the change, and notes that these are pre-audit figures. This type of disclosure is a standard regulatory requirement for listed companies to announce material financial changes, fitting the 'Earnings Release' (ER) category as it provides the initial announcement of financial performance highlights. FY 2020
2021-02-03 Korean
주주명부폐쇄기간또는기준일설정
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short regulatory notice regarding the closure of the shareholder register for the purpose of determining voting rights for an upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal regulatory announcement of a corporate action. Given it is a standard regulatory notification that does not fit into specific categories like dividend or share issuance, it is classified as a general regulatory filing.
2020-12-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details a change in shareholding (specifically a decrease in shares held by KPX Holdings in KPX Life Science). This type of filing is used to notify the market of significant changes in ownership stakes, which falls under the 'Major Shareholding Notification' category.
2020-11-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard South Korean regulatory disclosure form (often referred to as an 'Insider Trading Report' or 'Director/Major Shareholder Ownership Report') filed with the Financial Supervisory Service (FSS) and the Korea Exchange. It details changes in share ownership by a major shareholder (KPX Holdings) in KPX Life Science. While it involves share transactions, it is specifically a regulatory disclosure of ownership status rather than a simple 'Director's Dealing' (DIRS) or 'Major Shareholding Notification' (MRQ) in the Western sense, but it fits the 'Major Shareholding Notification' category best as it reports a change in significant ownership levels (a decrease from 30% to 21%).
2020-11-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.